BSLN:SWX
Basilea Pharmaceutica AG Allschwil
CHF 73.70
arrow_upward
+0.96%(+0.70) 1D
Nov 4, 5:31:16 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSLN...
Open
CHF 73.00
High
CHF 74.50
Low
CHF 72.40
Mkt. cap
991.14M
Avg. vol.
30.07K
Volume
52.74K
P/E ratio
19.24
52-wk high
CHF 75.80
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.45M
No. of employees
200
Open
CHF 73.00
High
CHF 74.50
Low
CHF 72.40
Mkt. cap
991.14M
Avg. vol.
30.07K
Volume
52.74K
P/E ratio
19.24
52-wk high
CHF 75.80
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.45M
No. of employees
200
News stories
From web sources and news partners
Quantisnow
·
4 minutes ago
Blue Owl Technology Finance Corp. Announces September 30, 2026 Financial Results
Virginia Business
·
39 minutes ago
Accendra Health could be delisted by NYSE
The Killeen Daily Herald
·
15 minutes ago
US stocks surge, and the Dow soars more than 1,500 points as oil prices tumble following US midterms
The Washington Post
·
2 hours ago
The S&P 500 climbs after Democrats sweep the midterms
Profile
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
About Basilea Pharmaceutica AG Allschwil